A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia

Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate

Waton Financial Limited Launches Limited Access to Beta Version of MoTA

HM Exploration Expands Lewis Pilley’s Project to ~60 km²

Brazilian Rare Earths Announces the Alurion Resources Limited Board of Directors and Chief Executive Officer

Backstageplay to Acquire Software, IP, and Databases from NeXT Sports Group

Negotiations have not yet succeeded, and a strike has begun on Eimskip's own vessels

Kaltura Wins Best Event AI Technology at Eventex 2026 For the Fourth Straight Year

Comet Lithium Announces Adoption of Semi-Annual Reporting

CIBC Asset Management announces CIBC ETF cash distributions for May 2026

TARGA APPOINTS RYAN WESTON AS NEW VICE PRESIDENT OF EXPLORATION

Zero Candida Announces Corporate Changes

Condor Achieves New Production Record Exceeding 15,000 boe/d with K-47 Tie In

Atlas Engineered Products Reports First Quarter 2026 Financial and Operating Results

Aramco : and PETRONAS Announce Transfer of Full Ownership of PRefChem to PETRONAS

Arya Resources Reports Broad Gold, Silver and Elevated Scandium Mineralization at the Twin Zone, Wedge Lake Project, Saskatchewan

Freehold Royalties Receives TSX Approval for Renewal of Normal Course Issuer Bid

DR. PHONE FIX ENTERS NEW BRUNSWICK THROUGH STRATEGIC ACQUISITION AND ADDITIONAL STORE EXPANSION

ZTEST Electronics Inc. Announces Fiscal 2026 Q3 Results with 13.9% Year Over Year Revenue Growth

ESgold Corp. Engages ICP Securities for Automated Market Making Services